Systemic sclerosis (scleroderma): who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

No stopped trial with a stated reason in this view.

Trials whose registry record says individual participant data (IPD) will be shared.

• A Study of AZD0120 in Autoimmune Diseases

  NCT07295847· AstraZeneca· Source

• Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

  NCT01793168· Sanford Health· Source

• Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

  NCT07691970· AstraZeneca· Source

• Rollover Study for Participants Who Have Completed a Previous Clinical Study with Anifrolumab (Saphnelo) and Clinically Benefited from Continued Treatment.

  2026-526419-13-00· AstraZeneca AB· Source

• A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases

  NCT07873931· Bristol-Myers Squibb· Source

• A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· Boehringer Ingelheim· Source

• A Trial in Healthy Adult Participants and Adults With Autoimmune Disease to Test How HBM7020 is Tolerated and Absorbed in the Body

  NCT07649265· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

• A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

  NCT06470048· Novartis Pharmaceuticals· Source

• A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.

  NCT07641634· Prolium Bioscience, Inc· Source

• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  NCT03816345· National Cancer Institute (NCI)· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Proteomics 1
• Flow Cytometry 1
• Immunohistochemistry 1
• Magnetic Resonance Imaging 1
• Cohort Studies 5

See which targets of this disease your abstract mentions, and go to the people working on them.